PyroGenesis Canada (PYRGF) Competitors $0.35 -0.01 (-2.22%) As of 03/31/2025 01:43 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock PYRGF vs. TERN, PROK, GOSS, CMPS, SEPN, CADL, DSGN, AVIR, ZYBT, and CRVSShould you be buying PyroGenesis Canada stock or one of its competitors? The main competitors of PyroGenesis Canada include Terns Pharmaceuticals (TERN), ProKidney (PROK), Gossamer Bio (GOSS), COMPASS Pathways (CMPS), Septerna (SEPN), Candel Therapeutics (CADL), Design Therapeutics (DSGN), Atea Pharmaceuticals (AVIR), Zhengye Biotechnology (ZYBT), and Corvus Pharmaceuticals (CRVS). These companies are all part of the "pharmaceutical products" industry. PyroGenesis Canada vs. Terns Pharmaceuticals ProKidney Gossamer Bio COMPASS Pathways Septerna Candel Therapeutics Design Therapeutics Atea Pharmaceuticals Zhengye Biotechnology Corvus Pharmaceuticals Terns Pharmaceuticals (NASDAQ:TERN) and PyroGenesis Canada (NASDAQ:PYRGF) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, dividends, community ranking, profitability, analyst recommendations, valuation, risk, institutional ownership and media sentiment. Does the MarketBeat Community believe in TERN or PYRGF? Terns Pharmaceuticals received 42 more outperform votes than PyroGenesis Canada when rated by MarketBeat users. CompanyUnderperformOutperformTerns PharmaceuticalsOutperform Votes4259.15% Underperform Votes2940.85% PyroGenesis CanadaN/AN/A Does the media refer more to TERN or PYRGF? In the previous week, PyroGenesis Canada had 1 more articles in the media than Terns Pharmaceuticals. MarketBeat recorded 4 mentions for PyroGenesis Canada and 3 mentions for Terns Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 0.65 beat PyroGenesis Canada's score of 0.17 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive PyroGenesis Canada 0 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do institutionals & insiders hold more shares of TERN or PYRGF? 98.3% of Terns Pharmaceuticals shares are owned by institutional investors. Comparatively, 0.0% of PyroGenesis Canada shares are owned by institutional investors. 15.1% of Terns Pharmaceuticals shares are owned by insiders. Comparatively, 47.7% of PyroGenesis Canada shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has more volatility and risk, TERN or PYRGF? Terns Pharmaceuticals has a beta of -0.3, meaning that its share price is 130% less volatile than the S&P 500. Comparatively, PyroGenesis Canada has a beta of 0.74, meaning that its share price is 26% less volatile than the S&P 500. Is TERN or PYRGF more profitable? Terns Pharmaceuticals has a net margin of 0.00% compared to PyroGenesis Canada's net margin of -115.14%. PyroGenesis Canada's return on equity of 0.00% beat Terns Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -32.76% -31.33% PyroGenesis Canada -115.14%N/A -60.81% Which has stronger valuation & earnings, TERN or PYRGF? PyroGenesis Canada has higher revenue and earnings than Terns Pharmaceuticals. PyroGenesis Canada is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns PharmaceuticalsN/AN/A-$90.21M-$1.13-2.44PyroGenesis Canada$9.14M7.19-$21.12M-$0.06-5.87 Do analysts rate TERN or PYRGF? Terns Pharmaceuticals currently has a consensus price target of $18.38, indicating a potential upside of 565.76%. Given Terns Pharmaceuticals' stronger consensus rating and higher probable upside, research analysts plainly believe Terns Pharmaceuticals is more favorable than PyroGenesis Canada.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60PyroGenesis Canada 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryTerns Pharmaceuticals beats PyroGenesis Canada on 9 of the 16 factors compared between the two stocks. Remove Ads Get PyroGenesis Canada News Delivered to You Automatically Sign up to receive the latest news and ratings for PYRGF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PYRGF vs. The Competition Export to ExcelMetricPyroGenesis CanadaPharmaceutical IndustryIndustrials SectorNASDAQ ExchangeMarket Cap$65.71M$6.90B$6.81B$7.79BDividend YieldN/A2.81%3.55%4.04%P/E Ratio-5.877.4221.6018.68Price / Sales7.19207.0073.4189.79Price / CashN/A65.6726.7834.64Price / Book-35.206.203.654.12Net Income-$21.12M$142.11M$792.10M$247.10M7 Day Performance-13.06%-8.90%-0.80%-3.81%1 Month Performance-16.19%-10.51%-1.51%-6.23%1 Year Performance11.22%-12.80%17.02%-1.89% PyroGenesis Canada Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PYRGFPyroGenesis CanadaN/A$0.35-2.2%N/A+11.2%$65.71M$9.14M-5.8790Gap DownHigh Trading VolumeTERNTerns Pharmaceuticals4.2106 of 5 stars$3.51+4.8%$18.30+421.4%-57.9%$298.14MN/A-2.9740PROKProKidney2.0421 of 5 stars$1.02+6.2%$5.00+390.2%-46.6%$297.50M$76,000.00-1.853GOSSGossamer Bio3.9223 of 5 stars$1.28-7.9%$9.20+618.8%-6.8%$290.84M$114.70M-4.00180CMPSCOMPASS Pathways3.3418 of 5 stars$3.11+0.3%$21.83+602.0%-65.6%$288.21MN/A-1.41120SEPNSepterna2.1007 of 5 stars$6.37+7.6%$34.00+433.8%N/A$282.85M$981,000.000.00N/AEarnings ReportUpcoming EarningsGap DownCADLCandel Therapeutics2.3005 of 5 stars$8.66+7.4%$21.00+142.5%+257.6%$281.24M$120,000.00-5.0160Gap DownDSGNDesign Therapeutics1.9585 of 5 stars$4.93+6.0%$8.00+62.3%-4.2%$279.84MN/A-5.8040Gap UpAVIRAtea Pharmaceuticals2.6448 of 5 stars$3.20-0.6%$6.88+115.0%-26.0%$273.68MN/A-1.5570ZYBTZhengye BiotechnologyN/A$5.80+18.9%N/AN/A$273.56M$189.75M0.00278High Trading VolumeCRVSCorvus Pharmaceuticals2.3125 of 5 stars$4.25-1.4%$12.38+191.2%+78.7%$273.09MN/A-4.5730Earnings Report Remove Ads Related Companies and Tools Related Companies TERN Alternatives PROK Alternatives GOSS Alternatives CMPS Alternatives SEPN Alternatives CADL Alternatives DSGN Alternatives AVIR Alternatives ZYBT Alternatives CRVS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PYRGF) was last updated on 4/1/2025 by MarketBeat.com Staff From Our PartnersNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | SponsoredLive Footage From Elon Musk’s “Area 51”What’s happening inside this nondescript building in South Memphis is so incredible… That Elon’s competitor...Brownstone Research | SponsoredTermination: 18F (read immediately)Have you ever heard of the government's 18F program? It helped manage digital services across the governmen...Altimetry | Sponsored10X Bigger than AI, quantum, EVs, crypto, and robotics combined?World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" Sam Altman, Bill Gates, and M...Stansberry Research | Sponsored“Massive Financial Reset Is Coming”The U.S. markets will see a massive reset, beginning days from now. But the "reset" isn't what you might ex...InvestorPlace | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PyroGenesis Canada Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PyroGenesis Canada With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PYRGF Stock Free PYRGF Stock Alerts